[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551522":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":23,"locations":34,"responsibleParty":51,"collaborators":22,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":9,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":22,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":36,"whyStopped":22,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Koo Foundation Sun Yat-Sen Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ga-68-CXCR4 PET\u002FCT in Indolent B-cell Lymphoma","EXPERIMENTAL","Indolent B-cell Lymphoma such as marginal-zone B-cell lymphoma、Waldenstrom macroglobulinemia lymphocytic lymphoma、CLL\u002FSLL、mantle cell lymphoma.",[13],"Drug: Ga-68-CXCR4",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Ga-68-CXCR4","Ga-68-CXCR4 for PET\u002FCT procedure in Indolent B-cell Lymphoma",[9],[21],"PET\u002FCT",null,[24,30],{"name":25,"role":26,"phone":27,"phoneExt":28,"email":29},"Yu Yi Huang, MD","CONTACT","+886 28970011","1121","yuyi@kfsyscc.org",{"name":31,"role":26,"phone":27,"phoneExt":32,"email":33},"Cheng Ling Yang, B.Rad.","1167","androgyny@kfsyscc.org",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Taipei","Beitou","1125019","Taiwan","TW",{"type":43,"coordinates":44},"Point",[45,46],121.52639,25.05306,{"lat":46,"lon":45},[49,50],{"name":25,"role":26,"phone":27,"phoneExt":28,"email":29},{"name":31,"role":26,"phone":27,"phoneExt":32,"email":33},{"type":52,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR","100551522","phase-2-ga-68-cxcr4-petct-in-indolent-b-cell-lymphoma-100551522",false,"NCT06461182","Ga-68-CXCR4 PET\u002FCT in Detecting, Evaluating Response to Treatment, and Monitoring Risk of Aggressiveness of Indolent B-cell Lymphoma","PentixaFor","Inclusion Criteria:\n\n* The pathological diagnosis is slow-growing lymphoma, such as: marginal-zone B-cell lymphoma, Waldenstrom macroglobulinemia lymphocytic lymphoma, CLL\u002FSLL, mantle cell lymphoma.\n* Have undergone or planned to undergo FDG PET scan for indications including initial staging, therapeutic response evaluation, or follow-up examinations within 3 to 6 months in the clinical observation group.\n* Able to lie flat for at least 30 minutes.\n* Signing the subject consent form.\n* ECOG grade 0-2.\n* The timing of F-18-FDG usage in this trial follows the \"Lymphoma Treatment Principles\" of our institution.\n\nExclusion Criteria:\n\n* Pregnant woman\n* Severe renal impairment (eGRF\\\u003C 30ml\u002Fmin)\n* Known or suspected allergy to radiopharmaceuticals\n* Concurrent or previous diagnosis of malignancies other than lymphoma\n* Inability to undergo the necessary PET scan procedure\n* Refusal or unwillingness to sign the informed consent form\n* Severe medical conditions (severe disabilities, mental disorders)","ALL","20 Years","100 Years",{"count":64,"type":65},15,"ESTIMATED","INTERVENTIONAL",[68],"PHASE2","This study explores the efficacy of Ga-68-PentixaFor PET\u002FCT in detecting, assessing treatment response, and monitoring the risk of aggressiveness in indolent B-cell lymphoma. The background introduces CXCR4 and discusses its role in cancer research. Currently, FDG-PET is the primary imaging tool for lymphoma staging, but it lacks diagnostic accuracy for low-grade lymphomas. Ga-68-PentixaFor PET demonstrates promising detection capabilities across various lymphomas, suggesting its potential as a superior imaging modality for low-grade lymphomas.",[71],"Indolent B-Cell Non-Hodgkin Lymphoma",[73,74],"Ga-68-CXCR4 PET\u002FCT","indolent B-cell lymphoma","2024-06-11",{"date":77,"type":78},"2024-06-14","ACTUAL",{"date":80,"type":78},"2024-04-29",{"date":82,"type":65},"2027-04",{"name":5,"class":6},1]